LGALS3 and systemic sclerosis: In addition to highlighting the association of Gal-3 and its interactants in SSc, this Gal-3 fingerprint could also serve as a stratification biomarker to discriminate patients based on disease features and/or inflammatory status in a targeted treatment approach.